secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001740797-26-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVAI Bio and Ainnova Tech mutually terminate JV agreement as of May 7, 2026
---------------------------------------------------------------------------

- No penalties incurred; all obligations and liabilities under the License Agreement (Nov 8, 2024) released.
- Joint venture Ai-Nova Acquisition Corp. (AAC) to be formally dissolved per Nevada law.
- Each party retains its own intellectual property; all cross-licenses revoked.
- Both parties execute mutual releases of all claims arising from the JV.
- Company states the termination reflects independent business strategies going forward.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079726000011/0001740797-26-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079726000011/avai_8kmay82026.htm
  HTML page:      https://secwatch.observer/filing/0001740797-26-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer